Terms: = Lung cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Staging
12 results:
1. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor.
Hua X; Feng W; Ye M; Lai M; Yu X; Sun M; Li J; Ai R; He Y; Cai L; Shi C; Liu X
Cancer Med; 2024 May; 13(9):e7206. PubMed ID: 38686619
[TBL] [Abstract] [Full Text] [Related]
2. runx1 promotes proliferation and migration in non-small cell lung cancer cell lines via the mTOR pathway.
Ma H; Jiang S; Yuan Y; Li J; Li Y; Lv Y; Du T; Guan J; Jiang X; Tian L; Zheng Q; Yang L; Li Q
FASEB J; 2023 Nov; 37(11):e23195. PubMed ID: 37801076
[TBL] [Abstract] [Full Text] [Related]
3. A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.
Zhou Q; Zhan Y; Guo J
BMC Gastroenterol; 2023 May; 23(1):177. PubMed ID: 37221487
[TBL] [Abstract] [Full Text] [Related]
4. Development and Validation of a Prognostic Model to Predict Overall Survival for lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter lung cancer Database.
Wang Z; Hu F; Chang R; Yu X; Xu C; Liu Y; Wang R; Chen H; Liu S; Xia D; Chen Y; Ge X; Zhou T; Zhang S; Pang H; Fang X; Zhang Y; Li J; Hu K; Cai Y
Technol Cancer Res Treat; 2022; 21():15330338221133222. PubMed ID: 36412085
[No Abstract] [Full Text] [Related]
5. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
6. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell lung cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract] [Full Text] [Related]
8. lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
[TBL] [Abstract] [Full Text] [Related]
9. Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer.
Harris JP; Nwachukwu C; Qian Y; Pollom E; Loo BW; Das M; Diehn M
Lung Cancer; 2018 Oct; 124():76-85. PubMed ID: 30268484
[TBL] [Abstract] [Full Text] [Related]
10. The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma.
Ozmen O; Koyuncu A; Koksal D; Tatci E; Alagoz E; Demirag F; Gokcek A; Arslan N
Nucl Med Commun; 2016 Jan; 37(1):43-9. PubMed ID: 26440572
[TBL] [Abstract] [Full Text] [Related]
11. The clinical utility of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in Turkish lung cancer patients.
Yüceege M; Sanisoğlu B; Fırat H; Ersoy Y; Sevgi E; Kurt EB
Clin Respir J; 2015 Apr; 9(2):221-7. PubMed ID: 25849299
[TBL] [Abstract] [Full Text] [Related]
12. Recommended changes for T and N descriptors proposed by the International Association for the Study of lung cancer - lung cancer staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract] [Full Text] [Related]